Argenx Se Bdr (A1RG34) Stock Price & News

Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia

About Argenx Se Bdr

CEO-

Employees1.86 мян

Founded2008 оны 4-р сарын 25

Headquarters-

SectorHealth Care

Industry-

Websiteargenx.com

All values in USD	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар	2026 оны 9-р сар
Revenue	1.31 тэрбум	1.31 тэрбум	1.54 тэрбум	1.75 тэрбум
Cost of goods sold	521.40 сая	564.00 сая	631.00 сая	668.00 сая
Cost of revenue	521.40 сая	564.00 сая	631.00 сая	668.00 сая
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	429.62 сая	355.00 сая	417.00 сая	448.00 сая
Operating expense	429.62 сая	355.00 сая	417.00 сая	448.00 сая
Total operating expenses	951.02 сая	919.00 сая	1.05 тэрбум	1.12 тэрбум
Operating income	359.56 сая	394.00 сая	493.00 сая	635.00 сая
Other non operating income	-907.00 мян	-	-1.00 сая	1.00 сая
EBT including unusual items	403.29 сая	426.00 сая	531.00 сая	538.00 сая
EBT excluding unusual items	391.71 сая	426.00 сая	531.00 сая	688.00 сая
Income tax expense	-129.66 сая	60.00 сая	59.00 сая	32.00 сая
Effective tax rate	-32.15%	14.08%	11.11%	5.95%
Other operating expenses	-	-	-	-
Net income	532.95 сая	366.00 сая	472.00 сая	506.00 сая
Net profit margin	40.67%	27.88%	30.63%	28.90%
Earnings per share	8.02	5.52	7.32	7.80
Interest and investment income	44.95 сая	44.00 сая	48.00 сая	45.00 сая
Interest expense	-	-1.00 сая	-1.00 сая	-1.00 сая
Net interest expenses	44.95 сая	43.00 сая	47.00 сая	44.00 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	361.38 сая	395.82 сая	501.50 сая	636.82 сая
Gain or loss from assets sale	-	-	-	-

Ask anything